Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CID-1067700
Cat. No.:
OB0225LY-0061
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
CID-1067700 is a small molecule compound with properties that inhibit tumor cell proliferation. It plays a role in cell signaling pathways.
Synonym:
314042-01-8; 2-(3-Benzoylthioureido)-5,5-dimethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylic acid; 2-(Benzoylcarbamothioylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic acid
CAS No.:
314042-01-8
Compound CID:
1067700
Formula:
C18H18N2O4S2
Formula Weight:
390.48
Specification
Relative Density:
1.410 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
CID-1067700 can be used to understand the mechanisms driving tumor progression and developed as potential drugs.
Library Information
Targets:
Ras
Receptors:
Rab7
Pathways:
GPCR/G protein; MAPK
Plate Number:
AOCL-1
Plate Location:
g3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
68 mg/mL; 174 mM
